4D Molecular Therapeutics Inc. (FDMT) Provides 4D-310 Program Update; Reports Q2

Go back to 4D Molecular Therapeutics Inc. (FDMT) Provides 4D-310 Program Update; Reports Q2
(NASDAQ: FDMT) Delayed: 14.55 +2.36 (19.36%)
Previous Close $12.19    52 Week High
Open $12.20    52 Week Low
Day High $15.03    P/E N/A 
Day Low $12.10    EPS
Volume 3,452,855